Context Therapeutics Inc..
CNTX.US | N/A
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The...Show More
Better Health for All
0
No evidence available to assess Context Therapeutics Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Context Therapeutics Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. While CEO compensation for Martin Lehr was reported as $860,681 in 2023, median employee compensation was not provided, preventing the calculation of the CEO-to-median-employee pay ratio.
1
Therefore, all KPIs must be omitted due to a lack of evidence.
Fair Trade & Ethical Sourcing
0
No specific, quantitative evidence was found in the provided articles regarding Context Therapeutics Inc.'s performance on fair trade and ethical sourcing metrics, including fair trade certification share, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend.
Honest & Fair Business
0
Context Therapeutics Inc. has a Code of Business Conduct and Ethics applicable to all directors, officers, employees, contractors, consultants, and agents.
1
This Code includes a non-retaliation clause for good faith reports and provides an anonymous hotline (1-833-731-1884) and website for reporting suspected violations.
2
These reports are to be promptly and thoroughly investigated, and employees are required to sign an acknowledgment form upon initial hire or receipt of the Code.
3
The Code also explicitly protects employees' rights to engage in 'Protected Activity' by communicating with government agencies.
4
The company reported that for the year ended December 31, 2021, one Form 3 (two transactions) and two Form 4s (two and eight transactions/holdings respectively) were not timely filed for three individuals.
5
The Board of Directors' Corporate Governance Guidelines state there will always be a majority of independent directors, and all current Audit Committee members are independent as defined by Nasdaq and SEC rules.
6
The Code of Business Conduct and Ethics strictly prohibits all forms of bribery and corruption, and requires compliance with anti-money laundering laws, U.S. Economic Sanctions, and Export Controls, including the United States Foreign Corrupt Practices Act of 1977 and the United Kingdom Bribery Act of 2010.
7
Kind to Animals
0
No specific information regarding Context Therapeutics Inc.'s (CNTX.US) practices or policies related to animal welfare, animal testing, alternative testing methods, or any other 'Kind to Animals' metrics was found in the provided articles. The articles primarily discussed general FDA policy changes regarding animal testing and industry trends, without providing company-specific data for CNTX.US.
No War, No Weapons
0
The provided articles focus on Context Therapeutics' corporate announcements, expanded access policy for investigational therapies, company purpose and values, and pipeline of T cell engaging bispecific antibody therapies for solid tumors. No information or data points are present in the articles that explicitly relate to arms manufacturing, military contracts, dual-use technologies, sales to sanctioned regimes, peacebuilding initiatives, conflict divestment, or any other metric relevant to the 'No War, No Weapons' ethical value. Therefore, all KPIs are omitted due to lack of evidence.
Planet-Friendly Business
0
No evidence was found in the provided articles regarding Context Therapeutics Inc.'s performance on any of the 'Planet-Friendly Business' KPIs. The articles focus on financial results, operational milestones related to drug development, and website terms of use, without disclosing any environmental metrics, policies, or initiatives.
Respect for Cultures & Communities
0
No specific data points or evidence related to Context Therapeutics Inc.'s respect for cultures and communities, community engagement, or cultural sensitivity were found across the provided articles. The articles primarily focus on company operations, clinical trials, employee biographies, and financial filings, without addressing any of the defined KPIs for this ethical value.
Safe & Smart Tech
0
The company's privacy policy, last updated June 15, 2022, states that users have rights to access, delete, and opt-out of data collection.
1
It also mentions that data is retained for legitimate business purposes.
2
Furthermore, the policy addresses rights related to CCPA and GDPR.
3
Zero Waste & Sustainable Products
0
No specific data related to CNTX.US or its performance against the 'Zero Waste & Sustainable Products' ethical value was found in the provided articles.
1
The articles either provide general regulatory guidance without company-specific metrics or explicitly state that no data is available for the company.
2